Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017

被引:0
作者
Blum, Maxim [1 ]
Geurtsen, Jeroen [2 ]
Herweijer, Eva [1 ]
Sarnecki, Michal [3 ]
Spiessens, Bart [4 ]
Diogo, Gil Reynolds [5 ]
Hermans, Peter [6 ]
Thelwall, Simon [7 ]
Bhattacharya, Alex [7 ]
Verstraeten, Thomas [1 ]
Poolman, Jan [2 ]
Hope, Russell [7 ]
机构
[1] P95 Epidemiol & Pharmacovigilance, Leuven, Belgium
[2] Janssen Vaccines & Prevent BV, Bacterial Vaccines Discovery & Early Dev, Leiden, Netherlands
[3] Janssen Vaccines, Bern, Switzerland
[4] Janssen Pharmaceut, Janssen Res & Dev, Infect Dis & Vaccines, Beerse, Belgium
[5] Janssen Cilag, High Wycombe, England
[6] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, South Africa
[7] UK Hlth Secur Agcy, London, England
关键词
ExPEC; Invasive E. coli Disease; IED; Incidence; Sepsis; Bacteraemia; Bloodstream infection; Fatality; Surveillance; Epidemiology; BLOOD-STREAM INFECTIONS; RISK-FACTORS; BACTEREMIA; BURDEN;
D O I
10.1017/S0950268824001584
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Extraintestinal pathogenic Escherichia coli (ExPEC) causes invasive E. coli disease (IED), including bacteraemia and (uro)sepsis, resulting in a high disease burden, especially among older adults. This study describes the epidemiology of IED in England (2013-2017) by combining laboratory surveillance and clinical data. A total of 191 612 IED cases were identified. IED incidence increased annually by 4.4-8.2% across all ages and 2.8-7.6% among adults >= 60 years of age. When laboratory-confirmed urosepsis cases without a positive blood culture were included, IED incidence in 2017 reached 149.4/100 000 person-years among all adults and 368.4/100 000 person-years among adults >= 60 years of age. Laboratory-confirmed IED cases were identified through E. coli-positive blood samples (55.3%), other sterile site samples (26.3%), and urine samples (16.6%), with similar proportions observed among adults >= 60 years of age. IED-associated case fatality rates ranged between 11.8-13.2% among all adults and 13.1-14.7% among adults >= 60 years of age. This study reflects the findings of other published studies and demonstrates IED constitutes a major and growing global health concern disproportionately affecting the older adult population. The high case fatality rates observed despite available antibiotic treatments emphasize the growing urgency for effective intervention strategies. The burden of urosepsis due to E. coli is likely underestimated and requires additional investigation.
引用
收藏
页数:8
相关论文
共 31 条
[1]  
Bagri S., 2023, WWW Document
[2]   Characteristics and Outcomes of Culture-Positive and Culture-Negative Pediatric Sepsis [J].
Baker, Alexandra H. ;
Leland, Shannon B. ;
Freiman, Eli ;
Herigon, Joshua C. ;
Eisenberg, Matthew A. .
JOURNAL OF PEDIATRICS, 2023, 263
[3]   Estimating the incidence and 30-day all-cause mortality rate of Escherichia coli bacteraemia in England by 2020/21 [J].
Bhattacharya, A. ;
Nsonwu, O. ;
Johnson, A. P. ;
Hope, R. .
JOURNAL OF HOSPITAL INFECTION, 2018, 98 (03) :228-231
[4]   Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London [J].
Blandy, O. ;
Honeyford, K. ;
Gharbi, M. ;
Thomas, A. ;
Ramzan, F. ;
Ellington, M. J. ;
Hope, R. ;
Holmes, A. H. ;
Johnson, A. P. ;
Aylin, P. ;
Woodford, N. ;
Sriskandan, S. .
JOURNAL OF HOSPITAL INFECTION, 2019, 101 (02) :120-128
[5]   Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review [J].
Bonten, Marc ;
Johnson, James R. ;
van den Biggelaar, Anita H. J. ;
Georgalis, Leonidas ;
Geurtsen, Jeroen ;
de Palacios, Patricia Ibarra ;
Gravenstein, Stefan ;
Verstraeten, Thomas ;
Hermans, Peter ;
Poolman, Jan T. .
CLINICAL INFECTIOUS DISEASES, 2021, 72 (07) :1211-1219
[6]   Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014 [J].
Bou-Antoun, S. ;
Davies, J. ;
Guy, R. ;
Johnson, A. P. ;
Sheridan, E. A. ;
Hope, R. J. .
EUROSURVEILLANCE, 2016, 21 (35) :9-17
[7]   Unbiased identification of risk factors for invasive Escherichia coli disease using machine learning [J].
Clarke, Erik ;
Chehoud, Christel ;
Khan, Najat ;
Spiessens, Bart ;
Poolman, Jan ;
Geurtsen, Jeroen .
BMC INFECTIOUS DISEASES, 2024, 24 (01)
[8]   Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals [J].
Doua, Joachim ;
Geurtsen, Jeroen ;
Rodriguez-Bano, Jesus ;
Cornely, Oliver A. ;
Go, Oscar ;
Gomila-Grange, Aina ;
Kirby, Andrew ;
Hermans, Peter ;
Gori, Andrea ;
Zuccaro, Valentina ;
Gravenstein, Stefan ;
Bonten, Marc ;
Poolman, Jan ;
Sarnecki, Michal .
OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (02)
[9]   A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality [J].
Feldman, Sarah F. ;
Temkin, Elizabeth ;
Wullfhart, Liat ;
Nutman, Amir ;
Schechner, Vered ;
Shitrit, Pnina ;
Shvartz, Racheli ;
Schwaber, Mitchell J. ;
Andremont, Antoine ;
Carmeli, Yehuda .
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (06) :879.e1-879.e7
[10]   Genomics and pathotypes of the many faces of Escherichia coli [J].
Geurtsen, Jeroen ;
de Been, Mark ;
Weerdenburg, Eveline ;
Zomer, Aldert ;
McNally, Alan ;
Poolman, Jan .
FEMS MICROBIOLOGY REVIEWS, 2022, 46 (06)